Cover Image

Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis /

Show other versions (2)

This book reviews successes and (remaining) challenges in vaccine development for the selected Neglected Tropical Diseases (NTD) of Leprosy, Leishmaniasis, Meliodoisis and Tuberculosis, which are a continuous burden for millions of people in affected areas worldwide. Written by frontline researchers...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Christodoulides, Myron (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2023.
Edition:1st ed. 2023.
Subjects:
Medical microbiology.
Vaccines > Biotechnology.
Biomaterials.
Immunology.
Biotechnology.
Medical Microbiology.
Biomaterials-Vaccines.
Applied Immunology.
Online Access:Link to Metadata
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network
  • (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK)
  • Part I: Leprosy
  • 2. Leprosy challenges to vaccine developers
  • (Dr Hua Wang, University of Glasgow, UK)
  • 3. Leprosy vaccine development
  • (Dr Khushboo Borah, University of Surrey, UK)
  • Part II: Tuberculosis
  • 4. Biomarkers in tuberculosis vaccine development
  • (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa)
  • 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK),
  • Animal models for tuberculosis (Dr. Hao Li, China Agricultural University, Beijing, China)
  • 7. BCG vaccination
  • (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK)
  • 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK)
  • 9. Fermentation in vaccine development (BCG) (Dr. Joanna Bacon, Public Health England, UK Government, London, UK)
  • Part III: Leishmaniasis: 10. Human leishmaniasis vaccination
  • (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran)
  • 11. Aspects of human leishmaniasis vaccine use
  • (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria)
  • 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK)
  • 13. Canine leishmaniasis vaccines
  • (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK)
  • Part IV: Melioidosis
  • 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India)
  • 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria).

Similar Items